Genfit S.A. (EPA:GNFT)
France
· Delayed Price · Currency is EUR 3.896
-0.010 (-0.26%)
May 12, 2025, 5:35 PM CET
Genfit Revenue
In the year 2024, Genfit had annual revenue of 70.69M EUR with 105.01% growth. Genfit had revenue of 9.59M in the half year ending December 31, 2024, a decrease of -32.01%.
Revenue
70.69M
Revenue Growth
+105.01%
P/S Ratio
2.74
Revenue / Employee
392.73K
Employees
180
Market Cap
193.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 70.69M | 36.21M | 105.01% |
| Dec 31, 2023 | 34.48M | 8.24M | 31.38% |
| Dec 31, 2022 | 26.25M | -59.11M | -69.25% |
| Dec 31, 2021 | 85.36M | 76.67M | 883.14% |
| Dec 31, 2020 | 8.68M | -30.29M | -77.72% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 45.17B |
| EssilorLuxottica Société anonyme | 26.51B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
Genfit News
- 5 days ago - GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents - GlobeNewsWire
- 8 days ago - GENFIT to Present Latest ACLF Research at EASL Congress 2025 - GlobeNewsWire
- 13 days ago - GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F - GlobeNewsWire
- 14 days ago - GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025 - GlobeNewsWire
- 18 days ago - GENFIT Reports Full-Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 weeks ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
- 7 weeks ago - GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders - GlobeNewsWire
- 2 months ago - Royalty Financing with HCRx: GENFIT Announces Approval of the Amendment of the Terms and Conditions of its 2025 OCEANEs - GlobeNewsWire